The results of real-world practice with glecaprevir/pibrentasvir for the treatment of chronic hepatitis C virus infection genotypes 1 and 3 in adolescents aged 12 to 17 years in the Moscow region - PDF (俄语)
版权所有 © Meskina E.R., Tselipanova E.E., Galkina L.A., 2023
此作品已接受知识共享署名-非商业性使用 4.0国际许可协议的许可。